[WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled: “Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.](https://wbbsec.com/press-releases/wbb-securities-invites-you-to-attend-the-upcoming-demy-colton-virtual-salon-titled-seven-years-after-fda-approval-what-have-we-learned-about-cell-and-gene-therapies/)
[WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled: “Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.](https://wbbsec.com/press-releases/wbb-securities-invites-you-to-attend-the-upcoming-demy-colton-virtual-salon-titled-seven-years-after-fda-approval-what-have-we-learned-about-cell-and-gene-therapies/)

On Friday, October 6, Steve Brozak, Managing Partner and President of WBB Securities will moderate a panel discussion titled: “Infectious Disease: From Neglect to Respect Made Possible by New Technologies” at the BioFuture forum in[...]

Read More about WBB SECURITIES PRESIDENT STEVE BROZAK WILL MODERATE A PANEL AT THE BIOFUTURE CONFERENCE ON FRIDAY, OCTOBER 6, 2023

For Immediate Release February 20, 2023 Cranford, NJ– Steve Brozak, DMH, President of WBB Securities today participated in a Biotech Showcase session titled, Capital Preservation: How to Preserve Capital and Retain Control of Your Research. It[...]

Read More about Steve Brozak, President of WBB Securities Participated in the 2023 Biotech Showcase Session Titled, Capital Preservation: How to Preserve Capital and Retain Control of Your Research